The authors concluded that aprepitant inhibits SP’s oxidizing effects by inducing the antioxidant effects of catalase and SOD in the U87 cell line, suggesting it as a potential candidate for controlling glioblastoma in animal models and clinical trials [83]. This evidence concerns the gene CAT and glioblastoma.